Zim Laboratories per share figures

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023
₹0.82₹1.19₹2.50₹3.54₹5.01
₹0.82₹1.19₹2.50₹3.54₹5.01
₹55.36₹55.36₹51.77₹49.00₹41.12
₹74.17₹69.98₹77.79₹75.41₹81.79
—₹9.26₹8.45₹3.34₹7.70
₹0.96₹0.96₹0.07−₹11.83₹0.17
5.45.44.94.94.9
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

ZIMLAB₹141.26

Zim Laboratories Limited

· Pharma & Health
₹ CrorePeersANUHPHRVALIANTLABAHCLALBERTDAVDWANBURYHALEOSLABSBAJAJHCARETHEMISMEDMcap ₹756 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
₹ per share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Basic EPS5.013.542.501.190.82
Diluted EPS5.013.542.501.190.82
Book Value per Share41.1249.0051.7755.3655.36
Revenue per Share81.7975.4177.7969.9874.17
Cash Flow per Share7.703.348.459.26—
Free Cash Flow per Share0.17-11.830.070.960.96
Shares Outstanding (cr)4.94.94.95.45.4
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.